Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,858 | 142,700 | 152,494 | 173,199 | 66,680 |
| Receivables | 2,427 | 4,145 | 4,512 | 2,236 | 3,150 |
| Other current assets | 0 | 0 | 0 | 0 | 830 |
| TOTAL | $139,526 | $150,613 | $157,366 | $175,854 | $70,660 |
| Non-Current Assets | |||||
| PPE Net | 2,615 | 2,387 | 2,440 | 2,073 | 5,920 |
| Intangibles | 3,881 | 3,889 | 3,866 | 3,945 | 0 |
| Other Non-Current Assets | 300 | 295 | 169 | 169 | 4,820 |
| TOTAL | $6,796 | $6,571 | $6,476 | $6,188 | $10,740 |
| Total Assets | $146,322 | $157,183 | $163,842 | $182,041 | $77,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,297 | 5,994 | 7,715 | 6,138 | 6,580 |
| Other current liabilities | N/A | N/A | N/A | N/A | 10,500 |
| TOTAL | $12,709 | $10,623 | $13,697 | $13,651 | $17,090 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,411 | 4,629 | 5,982 | 7,513 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,709 | $10,623 | $13,697 | $13,651 | $17,090 |
| Shareholders' Equity | |||||
| Common Shares | 3,747 | 3,754 | 3,592 | 3,613 | 3,020 |
| Retained earnings | 123,562 | 137,166 | 141,073 | 159,681 | 52,580 |
| Other shareholders' equity | 6,305 | 5,640 | 5,480 | 5,097 | 5,290 |
| TOTAL | $133,613 | $146,560 | $150,145 | $168,391 | $60,890 |
| Total Liabilities And Equity | $146,322 | $157,183 | $163,842 | $182,041 | $77,980 |